Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults

NCT06027554 is registered in ClinicalTrials.gov with UConn Health as lead sponsor.

NCT NCT06027554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06027554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
Lead sponsor
UConn Health
Phase
Phase 2
Overall status
Recruiting
Start date
October 7, 2024
Completion date
February 1, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, frailty, mild cognitive impairment